- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 587.8M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 587.7M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 587.4M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 587.4M sh |
| Shares Outstanding | Q2 2025 · Jun 30, 2025 | 586.21M sh |
| Dividends Paid | Q2 2025 · Jun 30, 2025 | $2.75B |
| Dividends Paid restated | Q2 2025 · Jun 30, 2024 | $557M |
| Capex | Q2 2025 · Jun 30, 2025 | $161M |
| Capex restated | Q2 2025 · Jun 30, 2024 | $118M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $9.18B |
| Operating Cash Flow restated | Q2 2025 · Jun 30, 2024 | $7.5B |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $0 |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q2 2025 · Jun 30, 2024 | $0 |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $2.1B |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $615M |
| Short Term Investments restated | Q2 2025 · Jun 30, 2024 | $733M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $135M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $154M |
| Cash And Equivalents restated | Q2 2025 · Jun 30, 2024 | $102M |
| Cash And Equivalents restated | Q2 2025 · Dec 31, 2023 | $100M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $32.6B |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $25.59B |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2024 | $23.34B |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $82.88B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $80.15B |
| Total Liabilities restated | Q2 2025 · Jun 30, 2024 | $74.55B |
| Total Assets | Q2 2025 · Jun 30, 2025 | $115.48B |
| Total Assets | Q2 2025 · Dec 31, 2024 | $105.75B |
| Total Assets | Q2 2025 · Jun 30, 2024 | $97.89B |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $5.40 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $9.77 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $2.48 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $6.42 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $5.42 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $9.80 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $2.49 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $6.45 |
| Net Income | Q2 2025 · Jun 30, 2025 | $3.18B |
| Net Income | Q2 2025 · Jun 30, 2025 | $5.74B |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $1.46B |
| Net Income restated | Q2 2025 · Jun 30, 2024 | $3.79B |
| Revenue | Q2 2025 · Jun 30, 2025 | $22B |
| Revenue | Q2 2025 · Jun 30, 2025 | $42.41B |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $18.13B |
| Revenue restated | Q2 2025 · Jun 30, 2024 | $35.38B |